Your institution may have access to this item. Find your institution then sign in to continue.
Title
Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.
Authors
Writing Committee for the CASCADE Collaboration
Abstract
To estimate the clinical benefit of highly active antiretroviral therapy (HAART) initiation vs deferral in a given month in patients with CD4 cell counts less than 800/μL.
Publication
Archives of internal medicine, 2011, Vol 171, Issue 17, p1560